Sandoz Says Feds Misclassified Generics As 'Innovator Drugs'

By Henrik Nilsson · April 11, 2024, 10:47 PM EDT

Pharmaceutical company Sandoz Inc. sued the Centers for Medicare & Medicaid Services in Washington, D.C., federal court on Wednesday, alleging the agency ignored the company's objection to classifying two of its generics...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

SANDOZ INC. v. BECERRA et al

Case Number

1:24-cv-01028

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

April 10, 2024